• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

SFC Fluidics lands JDRF support for interoperable insulin patch pump

July 30, 2018 By Sarah Faulkner

SFC FluidicsSFC Fluidics said today that it inked a deal with JDRF to support the development of an insulin patch pump with open-protocol communication features.

SFC Fluidics plans to use the two-year funding deal from JDRF to speed up the development of a patch pump that securely connects with other devices, like a continuous glucose monitor and third-party algorithms, to automate insulin delivery.

The funding deal is part of JDRF’s Open-Protocol Automated Insulin Delivery Systems Initiative, which launched last year with the goal to bring components that could be used in automated insulin delivery systems to the market faster.

SFC Fluidics plans to develop a patch pump that operates on the company’s platform and publish its communications protocols so that approved devices can communicate with the pump.

“There is a passionate group of people behind a patient-driven ecosystem, using do-it-yourself approaches to develop solutions to meet their needs. We believe SFC’s unique pumping technology will provide new options for them to live the lifestyle that suits them the best,” Anthony Cruz, CEO of SFC Fluidics, said in prepared remarks. “With our partnership with JDRF, we will bring new and innovative solutions to the diabetes community.”

“We are excited to support SFC in its open-protocol pump development as a key step toward the realization of our goal of an open-protocol AID ecosystem,” Daniel Finan, research director at JDRF, added. “We are hopeful that solutions such as this will greatly expand choice in the marketplace, increase adoption of advanced, life-improving technologies among people with T1D, and accelerate the cadence of innovation in these treatment options.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: Juvenile Diabetes Research Foundation (JDRF), sfcfluidics

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS